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Abstract  
Background 
Freshwater cyanobacteria are common inhabitants of recreational waterbodies throughout 
the world; some cyanobacteria can dominate the phytoplankton and form blooms, many 
of which are toxic. Numerous reports in the literature describe pruritic skin rashes after 
recreational or occupational exposure to cyanobacteria, but there has been little research 
conducted on the cutaneous effects of cyanobacteria. Using the mouse ear swelling test 
(MEST), we sought to determine whether three toxin-producing cyanobacteria isolates 
and the purified cyanotoxin cylindrospermopsin produced delayed-contact 
hypersensitivity reactions. 
Methods 
Between 8 and 10 female Balb/c mice in each experiment had test material applied to 
depilated abdominal skin during the induction phase and 10 or 11 control mice had 
vehicle only applied to abdominal skin. For challenge (day 10) and rechallenge (day 17), 
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test material was applied to a randomly-allocated test ear; vehicle was applied to the other 
ear as a control. Ear thickness in anaesthetised mice was measured with a micrometer 
gauge at 24 and 48 hours after challenge and rechallenge. Ear swelling greater than 20% 
in one or more test mice is considered a positive response. Histopathology examination of 
ear tissues was conducted by two groups of independent examiners.  
Results 
Purified cylindrospermopsin (2 of 9 test mice vs 0 of 5 control mice; p=0.51) and the 
cylindrospermopsin-producing cyanobacterium C. raciborskii (8 of 10 test mice vs 0 of 
10 control mice; p=0.001) were both shown to produce hypersensitivity reactions. Irritant 
reactions were seen on abdominal skin at induction. Two other toxic cyanobacteria 
(Microcystis aeruginosa and Anabaena circinalis) did not generate any responses using 
this model. Histopathology examinations to determine positive and negative reactions in 
ear tissues showed excellent agreement between both groups of examiners (κ = 0.83).  
Conclusions 
The irritant properties and cutaneous sensitising potential of cylindrospermopsin indicate 
that these toxicological endpoints should be considered by public health advisors and 
reservoir managers when setting guidelines for recreational exposure to cyanobacteria. 
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Background and Aims 
 
Cyanobacteria, also known as blue-green algae, are common inhabitants of freshwater 
lakes and reservoirs throughout the world. Under favourable conditions, certain 
cyanobacteria can dominate the phytoplankton within a waterbody and form nuisance 
blooms. Anecdotal and case reports have documented skin rashes associated with contact 
exposure to freshwater cyanobacteria, from recreational and occupational settings [1]. 
Some reports and health advisories refer to irritant reactions [2, 3 (p.32), 4], but there are 
also convincing reports of hypersensitivity reactions [5, 6]. By way of contrast, some 
cyanobacterial products appear to possess dermal anti-inflammatory properties [7, 8]. We 
present here the first report of pathological effects on mammalian skin by the alkaloid 
cyanotoxin cylindrospermopsin. 
 
There is little published research on the cutaneous effects of planktonic freshwater 
cyanobacteria. Human clinical studies are discussed in the accompanying paper by 
Stewart et al [9]. Only two reports referring to experimental cutaneous reactions to toxic 
freshwater cyanobacteria using animal models were found in the literature: van Hoof et al 
[10] reported no adverse effects in two experiments involving rabbits and guinea pigs. 
Torokne et al [11] suggest that exposure to heterotrophic bacterial lipopolysaccharides 
may explain some of their positive findings from non-axenic cynanobacterial 
preparations. A review and critique of these papers follows in the Discussion.  
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The MEST was chosen as a model to investigate sonicated suspensions of lyophilised 
freshwater cyanobacteria, with the reported advantages over guinea-pig models of cost-
effectiveness, reduced test duration and objective data generation as opposed to visual 
scaling [12]. Mouse ear swelling at the challenge phase was developed as a model of 
dermal sensitisation in the 1960s [13], refined and named the mouse ear swelling test by 
Gad et al [12], and the test was later revised [14]. Briefly, the procedure involves four 
applications of test material to the abdomen – the induction phase – followed by 
challenge application to the ear. A micrometer gauge is used to measure ear thickness; an 
increase in ear swelling of 20 per cent or greater in one or more test mice is regarded as a 
positive result [14].  
 
Using the MEST, we sought to determine whether three toxin-producing cyanobacteria 
isolates and the purified cyanotoxin cylindrospermopsin were capable of generating 
delayed-contact hypersensitivity reactions.  
 
 
Methods 
 
Cyanobacteria suspensions  
 
Three sonicated cyanobacterial suspensions were tested by separate MEST procedures: 
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• Microcystis aeruginosa – strain QH/NR/Ma/03/3 from the Queensland Health 
Scientific Services Culture Collection. This strain produces  microcystins, 
predominantly microcystin-LR (MC-LR). Microcystins are a group of >60 
structurally related cyclic peptide toxins; microcystins in this suspension were 
measured at 13.6 mg/L total microcystins expressed as MC-LR. 
• Anabaena circinalis – strain AWQC Gar 311FR from the Australian Water 
Quality Centre, Adelaide. This strain produces saxitoxins, which are structurally 
related alkaloid neurotoxins, measured at 6.0 mg/L total saxitoxins in this 
suspension. 
• Cylindrospermopsis raciborskii strain AWT 205 isolated and cultured from a 
Sydney ornamental lake [15] and supplied by Dr Peter Hawkins of Australian 
Water Technologies, Sydney. This strain produces the alkaloid toxin 
cylindrospermopsin, measured at 73mg/L in this suspension.  
 
Growth, harvesting, lyophilisation and storage of cells were conducted as described in the 
accompanying paper by Stewart et al [9]. A. circinalis was grown and harvested as per M. 
aeruginosa cells in 20L batch culture.  
 
Cyanobacteria preparations were made by mixing 200mg lyophilised cells in 10mL 
70%v/v ethanol in Milli-Q® filtered water to produce 2%w/v suspensions. Cell 
suspensions were steeped overnight at 4 0C. Cell integrity was disrupted by subjecting 
each suspension to ultrasonic pulsing for 30 seconds, using a Branson Ultrasonics 
Sonifier 450 instrument. Suspensions were stored at –20 0C prior to use. 
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Quantification of cyanotoxins 
 
Saxitoxins and microcystin-LR were analysed by HPLC with fluorescence detection 
using a Shimadzu LC10A system based on the methods of Lawrence et al [16] and 
Lawton et al [17] respectively. Cylindrospermopsin was quantified by HPLC-MS/MS 
with a Perkin Elmer series 200 HPLC coupled to a PE/Sciex API 300 mass spectrometer 
[18]. 
Cyanotoxins were quantified at Queensland Health Scientific Services laboratories. 
Saxitoxins were analysed by high performance liquid chromatography (HPLC) with 
fluorescence detection using a Shimadzu LC-10AVP system based on the methods of 
Lawrence et al [16]; microcystins were measured using a Shimadzu LC-10A HPLC with 
photodiode array detection using the methods of Lawton et al [17]. Cylindrospermopsin 
was quantified by HPLC-MS/MS with a Perkin Elmer series 200 HPLC coupled to a PE 
SCIEX API 300 mass spectrometer [18]. 
 
 
Cylindrospermopsin (CYN) solution 
 
Cylindrospermopsin was produced from strain AWT 205, grown in continuous culture as 
described in Stewart et al [9], isolated by solid phase extraction, purified by preparative 
HPLC and quantified by HPLC-MS/MS as described above. 1.15mL of a 521µg/mL 
solution of CYN in methanol was used, the solvent was evaporated under N2, and 6mL 
70% ethanol was added to produce a 100µg/mL solution.  
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DNCB solution 
 
A 0.1%w/v dinitrochlorobenzene (1-Chloro-2,4-dinitrobenzene, purchased from Sigma-
Aldrich P/L) in 70%v/v ethanol/water solution was used for a positive control MEST. All 
suspensions and solutions were stored at –20 0C prior to use.  
 
 
Mice 
 
Specific-pathogen-free female Balb/c mice were supplied by either Laboratory Animal 
Services, University of Adelaide, or bred in-house at QHSS Biological Research Facility. 
Mice were between 8 and 10 weeks of age, housed in groups of five with free access to 
food and water. An exercise wheel was placed in each cage for environmental 
stimulation.  
 
 
Other materials 
 
• Standard rodent chow enriched with vitamin A acetate 250IU/g was purchased 
 from Glen Forest Stock Feeds, Western Australia.  
• Freund’s complete adjuvant was purchased from Sigma-Aldrich P/L.  
 8
• A micrometer gauge, model 2046F was purchased from Mitutoyo Corp., Tokyo.  
• A proprietary depilatory cream (Nair brand; active ingredient calcium  thioglycolate 
<10%w/w) was purchased from a retail pharmacy. 
• A domestic mains-powered hair-dryer was purchased from a retail outlet. 
 
 
MEST procedures 
 
Preliminary investigations – MEST for irritancy 
 
The original approach to this work was to conduct modified MESTs for primary irritant 
reactions, as described by Patrick et al [19] and Patrick et al [20]. Six female mice from 
each of four strains (Balb/c, C57BL/6J, C3H/HeJ, C3H/HeJARC) were purchased from 
Animal Resources Centre, Canning Vale, W.A., and Animal Services Division, John 
Curtin School of Medical Research, Canberra, A.C.T. These mice were dosed with 
suspensions of M. aeruginosa (QH/NR/Ma/03, 5%w/v lyophilised cells in 75% 
methanol) and A. circinalis (non-toxic bloom sample, Gordonbrook Dam; 10% w/v in 
75% methanol). Test ears were dosed over four consecutive days; ear thickness 
measurements were taken at regular periods throughout. 
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MEST for delayed contact hypersensitivity (DCH) 
 
Briefly, the routine MEST procedures described by Gad [14] and followed in these 
experiments were: 
 
• All mice were supplied the vitamin-A enhanced diet for two weeks prior to any 
 procedures. This diet was maintained throughout the test. Vitamin A induces 
 epidermal hyperplasia in mice; most cell-mediated immune responses are 
 stimulated by vitamin-A supplementation [21]. 
• Abdominal fur was removed on Day 0; bilateral intradermal injections of 
 Freunds complete adjuvant were administered to all mice.  
• Abdominal skin was tape-stripped prior to dosing (except on Day 0 as  noted below 
and on affected animals per following discussion). 
• Test material was applied to the abdominal skin of test mice on days 0,1,3 and 5. 
 Vehicle only was similarly applied to the abdomens of control mice. Abdominal 
 skin was dried with a hair-dryer after each application. 
• Test ears of the test mice and five control mice were challenged with test material on 
day 10. Vehicle was applied to control ears. Ears were dried with a hair dryer. 
• Ear thickness was measured with a micrometer at 24 and 48 hours after 
 challenge dosing. 
• Ears of the test mice and the remaining five control mice were dosed with test 
 material on day 17 (rechallenge). Control ears were dosed with vehicle. 
• Ear thickness readings were done at 24 and 48 hours after rechallenge dosing. 
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 The following modifications to the methods of Gad [14] were employed: 
 
1. The test ear of each mouse was randomly assigned as either the left or right ear. 
2. Individual mice were identified by tail markings using a permanent marker pen. This 
is necessary for research purposes in order to allow random allocation of test ears, 
and for histopathological examination of ears.  
3. Abdominal fur was removed with depilatory cream. Tape stripping to remove the 
stratum corneum was performed on days 1, 3 and 5 (i.e. tape-stripping was not 
conducted on day 0, after depilatory treatment).  
4. Mice were anaesthetised for ear thickness measurements with a 50:50 mixture of 
CO2 and O2, as described by Blackshaw & Allan [22 (p.73)]. 
5. Two MEST experiments were conducted with fewer than 10 test mice due to 
anaesthesia-related deaths (n=2) and an unrecognised deformity of an ear pinna in 
one mouse (discussed in Stewart [23 (Chapter 5)]).  
 
At least two, and more frequently three micrometer readings were taken on each ear, 
depending on the time that each mouse remained motionless after CO2/O2 anaesthesia. 
Measurements were dictated onto audio cassette tape and later transcribed into a 
spreadsheet. The average of the two or three readings taken on each ear was used to 
determine differences in ear thickness between test ears and control ears. Percent ear 
swelling at each measurement period was determined by the formula: % ear swelling = 
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100*(A-B)/B where A denotes the mean test ear thickness and B denotes the mean 
control ear thickness.  
 
All challenge and rechallenge concentrations were the same as for the induction doses 
(2%w/v lyophilised cyanobacteria in 70%v/v ethanol), with the exception of the 
cylindrospermopsin MEST. In this test, the challenge dose was 20μL to the ventral pinna 
and 20μL to the dorsal pinna of each test ear using a 50μg/mL CYN in 70% ethanol 
solution, i.e. half the concentration of the induction dose. CYN rechallenge doses were 
performed with the normal induction concentration of 100μg/mL CYN in ethanol.  
 
 
Histopathology 
 
Mice were sacrificed by CO2 inhalation; ears from five test mice and five control mice in 
the CYN MEST were removed and fixed in 10% phosphate-buffered formalin. Ears from 
test mice that produced positive MEST responses were selected for histopathology 
examination. Ears from test mice in the C. raciborskii MEST were not considered in this 
examination as these mice were subjected to ear thickness measurements beyond day 19, 
i.e. past the 48-hour post-rechallenge period, in order to monitor their return to baseline.  
However, ears from three C. raciborskii MEST control mice were collected after the 48-
hour post-challenge measurements and prepared on microscopy slides. Ears from two 
mice in the A. circinalis and M. aeruginosa MESTs were also collected. Liver, kidney, 
spleen and lung tissue were harvested from three mice that were peak responders in both 
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the C. raciborskii and CYN MESTs (i.e. organs from six mice were prepared). These 
organs were fixed as for ears. Tissues were prepared at the School of Veterinary Science, 
Department of Veterinary Pathology (Histopathology), University of Queensland, stained 
with haematoxylin and eosin and mounted on glass slides for microscopic examination. 
Slides were identified with a double-letter code generated by spreadsheet random number 
and ranking functions, to allow the examiner to be blinded to the treatment status of each 
slide. Two examiners conducted histopathological examinations: 1st examiner was author 
AAS; 2nd examiners were an expert pathologist with specific expertise in pathology of the 
skin, plus a consultant dermatologist and three dermatology registrars. 2nd examiners 
reported each slide by consensus. Histopathological examination was conducted by 
presenting each pathologist with identified slides from one control ear and two test ears 
from the positive control MEST (0.1% DNCB) to allow for familiarisation with normal 
mouse ear morphology and type-IV hypersensitivity-related changes. All subsequent 
slides were read with the examiners blinded to their identity.  
 
 
Statistical analyses 
 
Fisher’s exact test was used to compare proportions of test ear increases greater than 20% 
between test and control mice. Histopathology inter-rater agreement was assessed using 
Cohen’s kappa (κ) statistic. Fisher’s exact test was used to examine the marginal 
homogeneity of the pathologist responses by comparing the unmatched distribution of 
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equivocal / normal / positive ratings. Statistical tests were performed with SPSS v.13.0, 
and p<0.05 was used to denote statistical significance. 
 
 
Ethical approval 
 
QHSS Animal Ethics Committee granted approvals for the original study protocol and all 
subsequent amendments under clearance number NRC 3/98/20 IS. 
 
 
Results  
 
MESTs for delayed-contact hypersensitivity 
 
Ear thickness increases, expressed as percent ear swelling, for the four cyanobacterial 
MESTs (M. aeruginosa, C. raciborskii, A. circinalis and purified cylindrospermopsin) 
and the positive control MEST (0.1% DNCB) are given in Table 1. Figures 1-3 are point 
plots showing ear thickness changes of individual mice in MESTs for DNCB, C. 
raciborskii and CYN. All mice dosed with DNCB registered ear thickness increases 
greater than 20%. Test ears were erythematous; some had obvious oedema. No mice 
dosed with 2%w/v suspensions of A. circinalis or M. aeruginosa reached 20% ear 
swelling. The MEST using a 2%w/v suspension of C. raciborskii containing 73µg/mL 
cylindrospermopsin (CYN) resulted in a clear median increase in ear swelling of test 
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animals; eight of ten test mice produced ear thickness increases of greater than 20% at 
challenge and/or rechallenge; no control mice gave ear thickness increases of >20%. The 
MEST for purified CYN produced ear thickness increases greater than 20% in two of 
nine test mice and none of five control mice following challenge doses of 50µg/mL CYN. 
After rechallenge with 100µg/mL CYN, four test mice and one of six control mice had 
ear thickness readings of >20%.  
 
 
Induction-phase reactions – C. raciborskii suspension and CYN 
 
As well as the ear thickness changes given in Table 1 and Figures 2 and 3, primary 
irritant reactions were seen on the abdominal skin of mice tested with the C. raciborskii 
suspension, and with purified CYN. No signs of irritancy were seen on the abdominal 
skin of mice treated with suspensions of M. aeruginosa or A. circinalis, or DNCB 
solution. The reaction seen on C. raciborskii and CYN-treated mice occurred on all test 
mice with varying degrees of severity. Figure 4 shows a test mouse with this reaction. 
Figure 5 shows a control mouse for comparison; vehicle only (70%v/v ethanol/water) 
was applied to the abdominal skin of control mice.  
 
Lesions produced on abdominal skin were noted from the second induction day onwards. 
Abdominal skin was dry, with yellowish/brown crusts and desquamation seen especially 
in inguinal areas and on upper hind limbs. Only very gentle tape-stripping was required 
in order to produce shiny abdominal skin, and in some mice with these lesions, tape 
 15
stripping was not performed when evidently painful (manifested by shrill vocalising and 
struggling). These lesions did not appear to be chronically painful when not disturbed, as 
affected mice were observed to be eating, sleeping and using their exercise wheel. More 
severely affected mice walked with an unusual gait, holding their abdomens clear from 
cage bedding. This was presumably in order to avoid contact by wood shavings with 
encrusted lesions, which, when dislodged, resulted in blood or serous fluid oozing from 
exposed skin. Healing was very rapid after induction dosing was complete; by the 
completion of the experiments at re-challenge (day 17), abdominal skin appeared 
essentially normal, with minor residual scarring seen on two animals.  
 
 
Histopathology 
1st examiner  
Test ears from two mice dosed with 0.1% DNCB were described as presenting with 
hyperemia, infiltration of inflammatory cells – mainly mononuclear cells with occasional 
polymorphonuclear leukocytes (PMNs); dilated lymphatic vessels and oedema (increased 
space between connective tissue).  Typical findings from the test ears of test mice dosed 
with cylindrospermopsin were: oedema, thickening, and inflammatory cell infiltration – 
mainly mononuclear cells, though varying degrees of PMN infiltration were also seen. 
One test ear slide showed an epidermal lesion, with hyperkeratinisation and associated 
PMN infiltration. The overall impression was of mostly mild inflammatory reactions to 
cylindrospermopsin, with occasionally more severe effects. No pathological changes 
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were seen in any of the organs (liver, spleen, kidney, lung) from mice cutaneously 
exposed to C. raciborskii suspension or cylindrospermopsin.  
 
 
2nd examiners  
 
Test ears from the two mice dosed with DNCB were described as inflamed, and rated 
“+++”. One ear from a cylindrospermopsin-challenged mouse was rated “+++ with 
eosinophilia”, and a control ear (i.e. vehicle-only treated) from another 
cylindrospermopsin-challenged mouse was rated “++ with some eosinophils”. Again, 
liver, kidney, lung and spleen tissues from all six mice dosed with C. raciborskii 
suspension or purified cylindrospermopsin were reported as normal.  
 
 
Measures of inter-rater agreement 
 
Table 2 presents results of microscopy examinations categorised into positive, negative 
and equivocal findings. There was no difference in the marginal distributions of the 
categories between raters (p=0.35) and there was excellent agreement beyond chance 
(κ=0.83, 95% CI: 0.61, 1.0).  
 
Figures 6 and 7 are examples of histopathology findings. Both slides (test ear and control 
ear) were prepared from ears taken from the same mouse. Note the test ear inflammatory 
cell infiltrate, thickening of dermal structures and the area of epithelial hyperplasia. 
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Discussion  
Preliminary investigations: MEST for irritancy 
No clear positive result was seen with either M. aeruginosa or A. circinalis, which were 
very concentrated preparations – these 5%w/v and 10%w/v concentrations being about 
the maximum amount of lyophilised cyanobacteria that could produce a viscous 
suspension. We then returned to the literature, and with some human case reports giving 
convincing descriptions of hypersensitivity reactions [5, 6], we decided to try the full 
MEST procedure for delayed-contact hypersensitivity.  
 
 
MESTs for delayed-contact hypersensitivity 
 
A MEST using M. aeruginosa suspension was the initial experimental investigation for 
hypersensitivity. Because of the negative response seen on abdominal and ear skin to the 
highest dose of M. aeruginosa suspension during pre-testing experiments, the MEST pre-
test irritancy screen in the methods of Gad [14] was dispensed with in order to limit the 
required number of experimental animals (Gad recommends at least eight mice for each 
MEST pre-test). As seen in Table 1, this MEST was negative, as no mice produced ear 
thickness increases greater than 20 percent. No abnormalities (erythema, oedema) were 
seen on the abdominal skin of any mice.  
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The next MEST was conducted with a sonicated suspension of C. raciborskii, at a 
concentration of 2%w/v in 70% ethanol, as per the previous MEST with M. aeruginosa. 
As the previous cutaneous-route experiment with toxic M. aeruginosa was negative, we 
reasoned that the experiment with C. raciborskii would probably elicit similar findings; 
therefore pre-testing experiments were again dispensed with. However, it became clear on 
day three of induction dosing, i.e. some 72 hours after the first induction dose, that a 
positive reaction was occurring. Dry, encrusted lesions were seen on the abdomens of all 
test animals – and on no control animals – from day three onwards. No abnormalities 
were seen on day one, i.e. 24 hours after the first dose. No observations were taken on 
day two, following the second induction dose, so it is not known whether these abdominal 
lesions would have been apparent any earlier than when first observed at 72 hours, 
following two dosings at 0 and 24 hours. Aware of the possibility that the reactions seen 
on abdominal skin would also be found on the test ears of control (i.e. naïve to C. 
raciborskii) mice, thus invalidating the MEST, we decided to proceed with the test. 
Fortunately, no such reaction was seen (see Table 1) in any of the ten mice used in 
challenge and rechallenge tests, thus confirming the findings of Gad [14], who notes that 
a concentration of test material that is irritating to one site – abdomen or ear – may not be 
an irritant concentration for the other. Irritant concentrations for ears are frequently higher 
than concentrations that will irritate abdominal skin [12]. Therefore this MEST has shown 
that a 2%w/v concentration of C. raciborskii suspension produces both a primary irritant 
reaction on mouse abdominal skin, and delayed-contact hypersensitivity. Unilateral 
erythema and swelling was seen on the ears of some test mice, similar to but of lesser 
intensity than the reactions seen on positive control MEST mice dosed with 0.1% DNCB. 
 19
No such reactions were seen on any control mouse ears. No signs of cutaneous injury 
similar to that seen on abdominal skin were observed on any ears. Reactions were more 
pronounced after rechallenge compared to challenge readings, as shown in Table 1 and 
Figure 2. 
 
A MEST to investigate a 2% w/v concentration of A. circinalis AWQC 311 GarFR was 
then conducted, but no positive findings were produced. 
 
Finally, we decided to conduct one more MEST using purified cylindrospermopsin, to 
investigate further the findings from the C. raciborskii MEST. The concentration was 
higher than the measured concentration of cylindrospermopsin in the 2% C. raciborskii 
suspension (100µg/mL cf 73µg/mL), therefore, again mindful of the risk of inducing an 
irritant reaction on the test ears of control mice, the challenge concentration of 
cylindrospermopsin (50µg/mL) was half that of the induction dose. Rechallenge was 
conducted with the induction concentration of 100µg/mL, but one of six control mice 
produced an ear swelling of  28%, therefore no clear statement can be made about these 
MEST rechallenge readings, as 100µg/mL cylindrospermopsin is most likely an irritant 
dose for the mouse ear. The effect size for the CYN MEST (control mice: p1 = 0/5 =0; 
test mice: p2 = 2/9 = 0.22) indicates that the statistical power to determine a significant 
difference of this size is less than 5%.  
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Reactions seen on abdominal skin in the cylindrospermopsin MEST were identical to 
those seen during the C. raciborskii MEST. Again, all test mice had visible lesions to 
varying degrees. Healing was rapid after the final induction dose on day 5, so that by day 
8, one mouse had a residual dry scab on the abdomen, and the remaining eight mice had 
essentially normal looking abdominal skin.  
 
Because of the different challenge dose used in the cylindrospermopsin MEST and the 
probable irritant reactions seen at rechallenge, it is not possible to make confident 
predictions about the relative contribution of cylindrospermopsin to the reactions seen in 
the C. raciborskii MEST. The number of mice used in the CYN MEST was too small to 
detect a statistically significant difference between proportions of test and control mice 
achieving the threshold ear thickness increases after challenge alone. However, the gross 
similarity of reactions seen on abdominal skin in both tests, and the fact that two test mice 
in the CYN MEST challenge test met the methodological criteria of Gad [14] for delayed-
contact hypersensitivity (i.e. a statistically non-significant but biologically significant 
finding) suggests that cylindrospermopsin is the major contributor to the outcome of the 
C. raciborskii MEST.  
 
There are several specific points of departure when attempting to apply the results of 
these findings to assessing the risk for humans in recreational or occupational contact 
with cylindrospermopsin-producing cyanobacteria:  
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• The concentration of cylindrospermopsin was well above that likely to be 
 encountered in natural waters (see following discussion). 
• Barrier function was disrupted by tape-stripping during the induction phase. 
 Removal of the stratum corneum by tape-stripping stimulates the release of pre-
 formed IL-1α and other inflammatory cytokines from the epidermis [24, 25]. 
• A vehicle (70% ethanol) was used to aid the transport of soluble factors across the 
epidermis. Matrix effects can be highly significant determinants of the potency of 
allergens, with reported variability of more than two orders of magnitude due to 
different vehicles [26].  
• Mice were immunologically primed to respond to sensitisers by use of 
 Freunds adjuvant and hypervitaminosis-A.  
 
However, the main aim of conducting animal models in this kind of exploratory work was 
to determine whether the mechanism of irritancy and hypersensitivity was feasible with 
these cyanobacterial preparations. Further investigation to determine dose-response 
relationships and cellular and molecular mechanisms should follow from this work.  
 
 
Histopathology 
 
Histopathology findings apparently revealed three false positive readings: firstly, the test 
ears from two control mice tested with 100μg/mL purified cylindrospermopsin at 
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rechallenge, i.e. test material applied to naïve mice. However, from Table 1 and Figure 3 
it seems clear that the rechallenge CYN concentration of 100μg/mL was an irritant dose 
for at least one mouse, as determined by an ear thickness increase greater than 20 per 
cent. Both pathologists rated the same two test ears as positive from this group of five 
control mice. One of these “false positive” test ears was from the mouse that produced a 
28% difference in ear thickness after rechallenge (Table 1 & Figure 3). Therefore, 
because both examiners rated the same two ears as having a positive reaction, and the 
dose applied to the ears of these naïve mice was probably in the irritant range, the most 
likely interpretation is that these were not false positive readings, but true positive 
findings. The 1st examiner described the slide from the mouse producing the 28% ear 
swelling reading as having “oedema, mild inflammatory infiltrate, with some 
polymorphs”; The 2nd examiner group rated this ear at “+++”.   
 
The other “false positive” reading is from a control ear, i.e. dosed with vehicle only. 1st 
examiner (author AAS) was twice presented with this slide; he reported it positive on 
both occasions, describing it as oedematous, with polymorph infiltration. The 2nd 
examiner group also described this slide as positive, rating it “++ with some eosinophils”. 
Therefore, it would appear that this slide also represented true positive histopathology. 
The explanation is not so obvious on this occasion: several possibilities spring to mind: 
 
1. The control ear was wrongly dosed with test material – in this case 
 cylindrospermopsin 100μg/mL CYN at rechallenge. 
2. The control ear was incorrectly identified post-mortem. 
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3. The ear was incorrectly identified during the staining and mounting process. 
4. The ear had encountered some unidentified trauma in the period before the 
 experiment ended, thus establishing an inflammatory reaction. 
 
Points 1 and 4 above seem unlikely to have occurred in this instance, as the ear thickness 
readings for this mouse throughout the MEST procedure were always positive, i.e. the 
test ear consistently produced higher micrometer readings than the control ear in question. 
Care was taken during the MEST procedure to prevent incorrect dosing of test and 
control ears: the test ears of all mice in each MEST were dosed and dried, then the 
container with the test suspension or solution was sealed, the container tube for the 
vehicle was opened, and each mouse was taken from its cage for dosing of control ears. 
The histopathology of the test ear from this mouse was also clearly positive: AAS 
described it as having cellular proliferation, polymorphs and mononuclear cells and 
oedema. DW’s group rated this test ear at “+++”.  
 
 No positive histopathology was seen in test ears of mice from the A. circinalis and M. 
aeruginosa MESTs; this supports the negative findings of both those MESTs.  In 
conclusion, the histopathology findings correlate well with the MEST results, and the two 
independent pathologist examinations demonstrate excellent agreement.  
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General Discussion 
Previously published animal models investigating cutaneous effects of freshwater 
cyanobacteria 
 
Two reports describing experimental cutaneous reactions to toxic freshwater 
cyanobacteria using animal models were found in the literature [10, 11]. The first, by van 
Hoof et al [10], was a conference poster presentation in which skin irritation and 
sensitisation tests were used in conjunction with LD50 and in vitro mutagenicity tests as a 
toxicity screen for bloom samples. Supernatants of four toxic M. aeruginosa strains were 
applied to the shaved skin of rabbits; patches were used to apply the supernatants. No 
signs of irritancy were observed at 24, 48 and 72 hours. Interpretation of the reported test 
for delayed contact hypersensitivity is more problematic. Notwithstanding the size 
limitations for such a presentation, it appears from the description of the methods that 
supernatants from two of the M. aeruginosa strains tested on rabbits were applied to the 
skin of guinea pigs (20 test animals plus 10 controls for each of the two tests) over a six-
hour period. Animals were then examined at 24 and 48 hours. If these experiments were 
conducted entirely within a 54-hour period, they were also tests for irritancy, not DCH. 
Either way, no adverse signs (“symptoms”) were found. Treatments applied to control 
guinea pigs were not reported. 
 
The other publication, by Torokne et al [11] is more detailed, but again some aspects of 
the report are difficult to interpret. Seven bloom samples, two non-axenic laboratory 
cultures and six axenic cultures were tested. Purified microcystin-LR (reported at a 
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concentration of 1.5mg/mL once in the abstract and 1.5μg/mL three times in the body of 
the report) was also tested. Cyanobacterial suspensions and cyanotoxin doses were 
apparently significantly lower than those used in this MEST work, although it is difficult 
to make reliable comparisons, as Torokne et al [11] used the intradermal induction route, 
whereas these MEST studies involved topical application. Estimated dose comparisons 
for the two sets of experiments (these MEST studies and Torokne et al [11] studies) are 
presented by Stewart [23 (Chapter 5)].  
 
Intradermal irritancy tests were conducted on rabbits; results were described as slight or 
negligible. Guinea pig maximisation tests were used for DCH determination; the reported 
proportion of sensitised animals ranged from 30% from two Microcystis blooms to 91% 
from an Aphanizomenon bloom. A non-axenic C. raciborskii preparation reportedly 
sensitised 50% of guinea pigs. These proportions were applied to allergen rating scales of 
“moderate allergen” for the Microcystis and C. raciborskii preparations to “extremely 
strong allergen” for the Aphanizomenon preparation [11].  
 
The difficulties in interpreting this work come from the reported percentages of sensitised 
guinea pigs, which are not derivable from the reported number of animals tested. Also, no 
details are given about the grading of end-points (erythema and oedema) in either test 
animals or controls; no photographic evidence of positive and negative reactions was 
published.  
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The authors noted that no irritant or DCH effects were seen with axenic cyanobacterial 
preparations, and therefore concluded that the lipopolysaccharides (LPS) of 
contaminating bacteria were implicated in their positive findings from non-axenic 
cyanobacteria [11]. The attribution of LPS involvement - cyanobacterial or otherwise - in 
skin pathology is uncertain at best, and the only references to reports of LPS-associated 
acute skin rashes appear to be from the cyanobacteria literature, with no specific research 
findings to support such attribution. The topic of cyanobacterial lipopolysaccharides and 
their pathogenicity was recently reviewed by Stewart et al [27]. If the findings of Torokne 
et al [11] can be repeated in other laboratories, supporting evidence such as 
histopathological examination of challenged skin would be helpful. 
 
In addition to the two papers discussed above examining cutaneous effects of toxic 
cyanobacteria are three papers describing: 1) cutaneous reactivity testing of a non-toxic 
cyanobacterium for food safety purposes; 2) subcutaneous challenge testing of non-toxic 
cyanobacteria for delayed-contact hypersensitivity, and 3) acute dermal toxicity of two 
purified cyanotoxins; 
 
Krishnakumari et al [28] reported dermal testing of Spirulina platensis, a non-toxic 
cyanobacterium. S. platensis is widely used as a human and animal food supplement [29]. 
The authors used an occlusive application technique to apply doses of up to 2g/kg to the 
dorsal skin of rats for 24 hours; the animals were observed for two weeks, with no signs 
of erythema or oedema reported. Like the study by van Hoof et al [10] discussed above, 
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Krishnakumari et al [28] suggest that they found no evidence of cutaneous allergy to their 
test cyanobacteria, whereas their study was clearly a test for primary irritancy. 
 
Shirai et al [30] describe an intraperitoneal induction and subcutaneous challenge test for 
delayed-type hypersensitivity, examining responses to non-toxic Microcystis bloom 
samples and an axenic non-toxic culture of M. aeruginosa. Mice were challenged two 
weeks after i.p. inoculation of cells by s.c. injection into a rear footpad, and increases in 
footpad thickness were measured. The authors report induction of delayed-type 
hypersensitivity by this mouse footpad swelling test, although it is not immediately clear 
from the methods and reported results how the authors demarcated irritant reactions from 
DCH reactions. Control mice reportedly showed increased footpad swelling, although the 
report does not state which material was administered to controls. We also have some 
concerns regarding the method, as there is no description of how footpad thickness was 
measured, and there was apparently no injection of solvent into the contralateral footpad, 
so it is not known whether or to what degree the challenge injection procedure may have 
contributed to footpad swelling [30]. 
 
Finally, Wannemacher et al [31] used guinea pigs to determine acute dermal toxicity of 
microcystin-LR (MC-LR) and saxitoxin, as well as other eukaryotic algal toxins and T2 
mycotoxin. Toxins were dissolved in dimethyl sulfoxide (DMSO) and applied to shaved 
dorsal skin. The dermal LD50s for saxitoxin and MC-LR were reported at 300µg/kg and 
2mg/kg respectively. These results are surprising, given that oral LD50s for MC-LR are 
reported as ranging from 3mg/kg to 11mg/kg in mice, and higher in rats [32, 33]. Oral 
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LD50s for saxitoxin range from 64µg/kg in neonatal rats, to 530µg/kg in adult rats, and 
260µg/kg in mice [32]. The use of DMSO as a vehicle may have contributed significantly 
to the trans-dermal transport of these highly water-soluble toxins into the circulation, 
hence the results of these experiments may not be readily interpretable from a human 
health risk perspective.  
 
 
Relative sensitising potency of cylindrospermopsin 
 
Understanding the relative potency of a toxin is an important step in defining the 
associated public health risk. This also applies to safety assessments of skin sensitisers, 
which may vary up to 10,000-fold in sensitising potency [34]. The induction and 
sensitisation concentrations of CYN in the C. raciborskii and CYN MESTs (50, 73 and 
100μg/mL) were artificially high, with field concentrations in lakes and ponds typically 
less than 1mg/L [35-37]. However, when considering these concentrations in the context 
of proposed thresholds for sensitising chemicals, 50μg/mL (0.005%w/v) and 100μg/mL 
(0.01%w/v) are in the range of concentrations to be classified as “extreme” sensitisers 
[34]. Therefore, DCH generated by CYN at any concentration below those used in these 
MESTs will, by this rating, still classify cylindrospermopsin as an extremely potent 
sensitiser.  
 
 29
Threshold concentrations can be determined for chemical sensitisers, and dose-response 
relationships are apparent in both induction and sensitisation phases [26, 34, 38 (pp.2, 3, 
17)]. If dose-response studies show that cylindrospermopsin is capable of eliciting DCH 
at lower concentrations than the artificially high doses used in these experiments, the 
appropriate question will be whether CYN at naturally occurring levels is below the 
threshold for DCH – and irritant reactions.  
 
 
Cylindrospermopsin – more than a hepatotoxin 
 
Cylindrospermopsin, a cyclic guanidine alkaloid, is well-recognised by 
cyanobacteriologists as a potent water-soluble toxin. Many workers describe 
cylindrospermopsin as a hepatotoxin, e.g. [39-42], because significant pathology is found 
in the livers of experimentally and accidentally poisoned animals. However, it is highly 
likely that CYN exerts toxic effects on other mammalian tissues, as administration of 
CYN-containing cyanobacteria damages kidney, thymus, heart, spleen, adrenals, lungs 
and the gastrointestinal tract [15, 43-45]. Purified CYN has been shown to produce 
pathologic effects on various organ systems – thymus, kidney and heart – as well as 
hepatic toxicity [46, 47].  
 
Other authors describe cylindrospermopsin as a generalised or non-selective cytotoxin, 
because multiple organs appear to be affected [48 (p.32), 49, 50 (p.3)]. This first report of 
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cylindrospermopsin-associated pathology of the skin lends support to the idea that this 
toxin is better described as a generalised or non-specific cyanotoxin.  
 
 
Improvements to the mouse ear swelling test 
 
Random allocation of test and control ears, as done in these MEST experiments, is a 
simple modification that should increase the reliability of the model. This technique 
allows the investigator to be blinded to the identity of test ears, provided that test 
materials do not affect the colour of test solutions. This and other modifications, and 
consideration of the MEST for regulatory and research purposes, are discussed in more 
detail by Stewart [23 (Chapter 5)]. 
 
 
Summary and Conclusions 
 
Using a mouse model of delayed-contact hypersensitivity, we have demonstrated that 
both a cylindrospermopsin-containing suspension of C. raciborskii and purified 
cylindrospermopsin elicit irritant and hypersensitivity reactions. Toxin-producing 
suspensions of M. aeruginosa and A. circinalis failed to induce any observable or 
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measurable adverse reactions. All three sonicated preparations were applied to mouse 
skin at identical concentrations (2%w/v lyophilised cyanobacteria).  
 
Further experimental work should follow in order to confirm positive and negative 
findings of this study and previously published work. Studies of the cellular and 
molecular processes involved in the cutaneous toxicity of cylindrospermopsin would be 
of great interest. 
 
Cylindrospermopsin-producing cyanobacteria are widely distributed in tropical, 
subtropical and temperate waters. Public health authorities and recreational water 
managers are aware of the potential for harm through accidental or deliberate ingestion of 
water contaminated by cylindrospermopsin; authorities may also need to consider the 
potential for cylindrospermopsin-producing cyanobacteria to be associated with 
complaints of acute skin reactions.  
 
 
Abbreviations 
 
CI   confidence interval 
 
CYN   cylindrospermopsin 
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 DCH   delayed-contact hypersensitivity 
 
DNCB   dinitrochlorobenzene 
 
HPLC   high performance liquid chromatography 
 
HPLC-MS/MS HPLC + tandem mass spectrometry 
 
i.d.   intradermal  
 
i.p.   intraperitoneal 
 
LD50   lethal dose for 50% of test animals 
 
LPS   lipopolysaccharide(s) 
 
MC-LR  microcystin-LR 
 
MEST   mouse ear swelling test 
 
NRCET  National Research Centre for Environmental Toxicology 
 
 33
OECD   Organisation for Economic Co-operation and Development 
 
PMN   polymorphonuclear leukocyte 
 
QHSS   Queensland Health Scientific Services 
 
RBH   Royal Brisbane Hospital 
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Figure 1 
Point plot showing individual mouse ear thickness changes: DNCB MEST (positive 
control experiment). 
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Figure 2 
Point plot showing individual mouse ear thickness changes: C. raciborskii MEST 
(suspension contained 73µg/mL CYN). 
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Point plot showing individual mouse ear thickness changes: cylindrospermopsin MEST  
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 Figure 4 
Reaction seen at induction phase – cylindrospermopsin 100µg/mL in 70% ethanol 
 
 
 
 
 
Figure 5 
Cylindrospermopsin MEST control mouse at induction phase - dosed with vehicle (70% 
ethanol) 
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Figure 7 
Cylindrospermopsin MEST, test ear. 
Cylindrospermopsin MEST, control ear (vehicle only).  
Figure 6 
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TEST SUBSTANCE Number of mice 
per test group 
with ear swelling 
>20% after 
challenge 
Number of mice 
per test group with 
ear swelling >20% 
after re-challenge 
Ear swelling (%) of 
highest responder 
test mouse after 
challenge * 
Ear swelling 
(%) of highest 
responder test 
mouse after re-
challenge * 
Percentage ear 
swelling of test 
group after 
challenge  
Median (range)** 
Percentage ear 
swelling of test 
group after re-
challenge  
Median (range)** 
Per cent ear 
swelling of 
highest responder 
control mouse 
after challenge 
and re-challenge 
Fisher’s exact test 
comparing 
proportion of ear 
thickness increases 
>20% between test 
and control mice 
 
0.1% DNCB 
 
10 Not done 130 Not done 81 (50 – 130) Not done Not done  
 
2% w/v 
M. aeruginosa 
microcystins 13.6 µg/mL 
0 0 11 6.5 3.5 (-11.6 – 10.7) 1.6 (-1.5 – 6.5) 8.9  
 
2% w/v 
A. circinalis 
saxitoxins 6.0 µg/mL 
0 0 8.2 9.5 0.0 (-6.8 – 8.2) 1.6 (-2.5 – 9.5) 11.7  
 
2% w/v 
C. raciborskii 
(CYN 73 µg/mL) 
4 
n=2 at 24 hrs  
n=2 at 48 hrs 
6 
n=6 at 24 hrs  
n=2 at 48 hrs 
38.9 47.5 17.6 (7.0 – 31.6) 25.0 (5.8 – 47.5) 10.7 p=0.001 
 
100µg/mL CYN+
2 
n=1 at 24 hrs  
n=1 at 48 hrs 
4 
n=1 at 24 hrs  
n=3 at 48 hrs 
26.1 49.2 8.2 (0.0 – 22.0) 13.1 (4.5 – 49.2) 4.8 (challenge)  27.8 (re-challenge) 
p=0.51 (challenge) 
p=0.58 (rechallenge) 
Table 1. Mouse ear swelling tests (MESTs): positive control + three cyanobacteria suspensions + purified cylindrospermopsin. 
Tables 
* ear measurements recorded at 24 and 48 hours after challenge/re-challenge. Tabled results are the higher of the two readings. 
 
**  tabled results show higher median and associated range from either 24 or 48 hour post-dose measurements. 
 
+ challenge concentration applied to test ears was 50µg/mL. Rechallenge concentration was 100µg/mL (= induction concentration). 
  
  
Table 2. Histopathology results – mouse ear swelling test.  
 
                       1st examiner (author AAS) 
 Positive Normal Uncertain Total 
Positive 7 0 0 7 
Normal 2 21 2 25 
Uncertain 0 0 0 0 
2n
d  e
xa
m
in
er
s 
(D
W
 &
 IR
) 
Total 9 21 2 32 
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